Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
GlobeNewswire, Inc.
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies showing that ClC-1 inhibition improves neuromuscular transmission and muscle function NMD Pharma is...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire, Inc.
Company announcement – No. 34 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S...
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
GlobeNewswire, Inc.
Company announcement No. 33 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 29, 2026) Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
GlobeNewswire, Inc.
STAFFORD, Texas, July 20, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Nasdaq Reports Second Quarter 2026 Results; $1.5 Billion in Net Revenue and Historic Milestones Reflect Broad-Based Momentum
GlobeNewswire, Inc.
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the second quarter of 2026. Second quarter 2026 net revenue1 was $1.5 billion, an increase of 15% on both a reported and adjusted2 basis...
Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
GlobeNewswire, Inc.
Three-year data from phase 2 trial will provide additional insights into potentially enhanced treatment effects and durability of the EVX-01-induced immune response Data will also offer insight into the vaccine’s effect also as stand-alone...
Alpine Psychiatry Offers Comprehensive Mental Health Services Across Pennsylvania
EIN Presswire
Clinician-owned practice provides in-person and virtual psychiatric care and therapy to patients across Pennsylvania, New Jersey, and New York. KING OF PRUSSIA, PA, UNITED STATES, July 16, 2026 /EINPresswire.com/ -- Alpine Psychiatry, a...
Europe's Biochar Market Set to Grow $1,338.3 kilotons by 2035 as EU Regulation Takes Hold
EIN Presswire
Germany led with a 27.0% share of the Europe Biochar Market in 2025, supported by federal carbon-removal funding and municipal heat-integration mandates.
Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight
GlobeNewswire, Inc.
New York, USA, July 16, 2026 (GLOBE NEWSWIRE) -- Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight The Parkinson's disease clinical trial analysis report delivers important...
Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress
GlobeNewswire, Inc.
Sutacimig Phase 2 long-term extension (LTE) data show sustained bleed reduction and manageable safety and tolerability; Phase 3 initiation planned 2H 2026 Preclinical data for sutacimig in Factor VII deficiency (FVIID) demonstrate restoration of...
Airengy and Nobian to jointly explore 2.5 GWh Compressed Air Energy Power Plant (CAPP) in Denmark
EIN Presswire
The intended compressed air power plant in Denmark adds to Airengy's previous compressed-air power plant projects in England, Romania, and Germany.
Elevara Medicines Appoints Biotech Veteran as CEO
GlobeNewswire, Inc.
Elevara Medicines Appoints Biotech Veteran as CEO Founder and former CEO of Nasdaq listed IO Biotech, Dr Mai-Britt Zocca appointed CEO Experienced chief executive with extensive operational and strategic experience in the international...
Zealand Pharma - Transactions related to share buy-back program (week 28, 2026)
GlobeNewswire, Inc.
Company announcement No. 32 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 28, 2026) Copenhagen, Denmark, July 13, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
TD2 Oncology and Minerva Imaging Partner to Expand Radiopharmaceutical Development Support
EIN Presswire
TD2's clinical and regulatory experience pairs with Minerva's imaging and CDMO services to support radioligand therapy through first-in-human trials.
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
GlobeNewswire, Inc.
HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater than or equal to 2.4-fold peak increases in Von Willebrand Factor (VWF) and Factor VIII (FVIII), normalization of peak thrombin generation and activated partial...
York U awarded $2.5M to investigate, mitigate impact of increasing digital surveillance on refugees
GlobeNewswire, Inc.
Toronto, July 22, 2026 (GLOBE NEWSWIRE) -- In a climate where walls and detention centres are built, border enforcement agencies expanded and new border control technologies adopted, there is a risk of global displacement, already at a historic...
South Korea and Denmark Partner on AI-Enabled Healthy Ageing and Dementia Prevention
EIN Presswire
South Korean and Danish partners develop AI-enabled prevention solutions supporting healthy ageing, independence and sustainable welfare systems.
Smartpatient and Novo Nordisk Set a New Standard for Connected Care for People with Metabolic Diseases in Germany
EIN Presswire
MUNICH, GERMANY, July 8, 2026 /EINPresswire.com/ -- Smartpatient and Novo Nordisk have launched a new digital support program for people living with Type 2 diabetes in Germany.
Zealand Pharma - Transactions related to share buy-back program (week 27, 2026)
GlobeNewswire, Inc.
Company announcement No. 31 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 27, 2026) Copenhagen, Denmark, July 6, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Potato Protein Market to Reach US$461.2 Mn by 2033 Driven by Plant-Based Nutrition
EIN Presswire
The global potato protein market set to reach US$296.8 Mn in 2026 and US$461.2 Mn by 2033, growing at a CAGR of 6.5% during 2026–2033 forecast period LONDON, ENGLAND, UNITED KINGDOM, July 6, 2026 /EINPresswire.com/ -- The global potato protein...
Sign up for:
Healthcare Times Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.